Penumbra announced the launch of the Lightning Flash 3.0 computer assisted vacuum thrombectomy (CAVT) system for the ...
The key opportunities in the Blood Clot Retrieval Devices Market involve advancing device technology and improving supply ...
Venous thromboembolism (VTE) is a leading cause of preventable hospital-acquired morbidity and mortality. Despite the availability of effective prophylaxis, its application in clinical practice ...
ALAMEDA, Calif., Nov. 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), which found that the use of ...
Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U.S. hospitals each year - and kills about one in five high-risk patients, according to the ...
Penumbra took the TCT (Transcatheter Cardiovascular Therapeutics) by storm on Sunday with the results of its landmark STORM-PE randomized controlled trial. The Alameda, CA-based company reported that ...
ALAMEDA, Calif., Oct. 27, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical ...
SAN FRANCISCO, CA—Patients with acute intermediate-high-risk pulmonary embolism (PE) who undergo mechanical thrombectomy have a greater reduction in the RV/LV ratio at 48 hours than those treated with ...
This summer I wrote an article about my experience with a postsurgical pulmonary embolism, hoping that sharing my story would help others take their own medical warning signs seriously. Hundreds of ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the company’s Symphony® ...
Background: Vitamin D deficiency (VDD) may contribute to venous thromboembolism (VTE) through effects on coagulation and endothelial function, but existing studies show inconsistent results. We ...
Pulmonary embolism (PE) can be a life‐threatening condition. Endovascular treatment is emerging as a promising treatment to restore hemodynamic stability and reverse right ventricular (RV) dysfunction ...